Altamira Therapeutics (CYTO) Stock Chart & Stock Price History → Altcoin FRENZY Alert… (From Crypto 101 Media) (Ad) Free CYTO Stock Alerts $2.07 -0.28 (-11.91%) (As of 03/28/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Altamira Therapeutics Stock Price Performance5 Day Performance+28.32%1 Month Performance+21.98%3 Month Performance-31.48%6 Month Performance-52.77%Year-To-Date Performance-36.21%1 Year Performance-90.83% Receive CYTO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Altamira Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaMajor Elon Musk Crypto Leak RevealedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. CYTO Stock Chart for Thursday, March, 28, 2024 CYTO Chart by TradingView Altamira Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/27/2024$2.42$2.35-2.89%$2.40$2.22327,601 shs$3.71 million03/26/2024$2.35$2.42+2.98%$2.45$2.171.05 million shs$3.82 million03/25/2024$1.73$2.35+35.84%$3.49$2.1062.76 million shs$3.71 million03/22/2024$1.68$1.72+2.38%$1.73$1.6543,144 shs$2.72 million03/21/2024$1.69$1.68-0.59%$1.69$1.6324,580 shs$2.65 million03/20/2024$1.68$1.69+0.60%$1.72$1.6223,647 shs$2.67 million Get the Latest News and Ratings for CYTO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Altamira Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 03/19/2024$1.69$1.68-0.59%$1.74$1.6224,181 shs$2.65 million03/18/2024$1.73$1.69-2.31%$1.73$1.6364,720 shs$2.67 million03/15/2024$1.68$1.73+2.98%$1.73$1.6823,871 shs$2.73 million03/14/2024$1.85$1.68-9.19%$1.82$1.6363,929 shs$2.65 million03/13/2024$1.87$1.85-1.07%$1.95$1.8119,894 shs$2.92 million03/12/2024$1.89$1.87-1.06%$1.90$1.8024,059 shs$2.96 million03/11/2024$1.88$1.89+0.53%$1.92$1.8281,045 shs$2.99 million03/08/2024$1.88$1.88$1.94$1.8230,663 shs$2.97 million03/07/2024$1.86$1.88+1.08%$1.92$1.7652,814 shs$2.97 million03/06/2024$2.02$1.86-7.92%$2.10$1.75244,506 shs$2.94 million03/05/2024$2.37$2.02-14.77%$2.67$2.00712,898 shs$3.19 million03/04/2024$2.43$2.37-2.47%$2.74$2.101.02 million shs$3.75 million03/01/2024$1.88$2.43+29.26%$2.46$1.88729,060 shs$3.84 million02/29/2024$1.82$1.88+3.30%$1.94$1.7735,797 shs$2.97 million02/28/2024$1.82$1.82$1.83$1.7921,809 shs$2.88 million02/27/2024$1.84$1.82-1.09%$1.87$1.8124,491 shs$2.88 million02/26/2024$1.80$1.84+2.22%$1.87$1.8019,295 shs$2.91 million02/23/2024$1.84$1.80-2.17%$1.85$1.7617,835 shs$2.84 million02/22/2024$1.78$1.84+3.66%$1.86$1.7335,646 shs$2.91 million02/21/2024$1.88$1.78-5.59%$1.97$1.7470,195 shs$2.80 million02/20/2024$1.91$1.88-1.57%$1.93$1.8744,151 shs$2.97 million02/19/2024$1.91$1.91$1.97$1.8229,600 shs$3.01 million02/16/2024$1.87$1.91+2.14%$1.97$1.8229,658 shs$3.02 million02/15/2024$1.81$1.87+3.31%$1.88$1.8126,269 shs$2.95 million02/14/2024$1.79$1.81+1.12%$1.89$1.7930,452 shs$2.86 million02/13/2024$1.86$1.79-3.76%$1.92$1.7632,344 shs$2.83 million02/12/2024$1.91$1.86-2.62%$1.93$1.8139,249 shs$2.94 million02/09/2024$1.87$1.91+2.14%$1.99$1.8152,793 shs$3.02 million02/08/2024$1.80$1.87+3.89%$1.88$1.74103,059 shs$2.96 million02/07/2024$1.73$1.80+4.05%$1.91$1.62887,505 shs$2.84 million02/06/2024$1.71$1.73+1.17%$1.80$1.6560,986 shs$2.73 million02/05/2024$1.78$1.71-3.93%$1.77$1.6248,644 shs$2.70 million02/02/2024$1.81$1.78-1.66%$1.80$1.7162,826 shs$2.81 million02/01/2024$1.85$1.81-2.16%$1.91$1.8046,922 shs$2.86 millionTrump’s “Tax Free” Retirement Strategy (Ad)Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar…01/31/2024$2.00$1.85-7.50%$2.00$1.8166,721 shs$2.92 million01/30/2024$2.02$2.00-0.99%$2.04$1.9251,885 shs$3.16 million01/29/2024$2.00$2.02+1.00%$2.02$1.78112,499 shs$3.19 million01/26/2024$2.13$1.99-6.57%$2.09$1.9596,806 shs$695,000.0001/25/2024$2.28$2.13-6.58%$2.20$2.00185,444 shs$746,000.0001/24/2024$2.10$2.28+8.57%$2.59$2.122.29 million shs$798,000.0001/23/2024$2.25$2.10-6.67%$2.25$1.9174,815 shs$735,000.0001/22/2024$2.22$2.25+1.35%$2.34$2.2032,845 shs$788,000.0001/19/2024$2.40$2.22-7.50%$2.34$2.2145,012 shs$777,000.0001/18/2024$2.46$2.40-2.44%$2.48$2.3656,128 shs$840,000.0001/17/2024$2.68$2.46-8.21%$2.67$2.3485,274 shs$861,000.0001/16/2024$2.71$2.68-1.11%$2.91$2.57124,580 shs$935,000.0001/15/2024$2.71$2.71$2.95$2.68150,400 shs$948,000.0001/12/2024$2.74$2.71-1.09%$2.95$2.68147,699 shs$948,000.0001/11/2024$2.92$2.74-6.16%$3.14$2.69176,773 shs$956,000.0001/10/2024$3.10$2.92-5.81%$3.18$2.91110,983 shs$1.02 million01/09/2024$3.12$3.10-0.64%$3.25$3.0465,781 shs$1.09 million01/08/2024$3.12$3.12$3.22$3.0159,657 shs$1.09 million01/05/2024$3.19$3.12-2.19%$3.27$3.1043,263 shs$1.09 million01/04/2024$3.33$3.19-4.20%$3.35$3.1925,579 shs$1.12 million01/03/2024$3.46$3.33-3.76%$3.51$3.10135,212 shs$1.17 million01/02/2024$3.48$3.46-0.57%$3.60$3.19187,731 shs$1.21 million01/01/2024$3.48$3.48$3.53$2.911.26 million shs$1.22 million12/29/2023$3.24$3.48+7.41%$3.53$2.911.25 million shs$1.22 million12/28/2023$2.78$3.24+16.55%$3.57$2.80583,301 shs$1.13 million12/27/2023$2.72$2.78+2.21%$2.89$2.55248,753 shs$973,000.00 Related Companies: PXMD Stock Price Chart NTBL Stock Price Chart BPTS Stock Price Chart SNPX Stock Price Chart GNPX Stock Price Chart ARDS Stock Price Chart GOVX Stock Price Chart KTRA Stock Price Chart JAGX Stock Price Chart PHAS Stock Price Chart Receive CYTO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Altamira Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CYTO) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaFed launches fourth dollar overhaulStansberry ResearchBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the MarketsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research Advisory Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Altamira Therapeutics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.